
Provider: Macmillian Magazines Ltd.
Content: application/x-research-info-systems
TY  - JOUR
AU  - Matloubian, M.
AU  - 
Concepcion, R. J.
AU  - Ahmed, 
R.
TI  - CD4+ T cells are required to sustain
CD8+ cytotoxic T-cell responses during chronic viral infection.

JA  - J. Virol.
PY  - 1994///
VL  - 68
SP  - 8056
EP  - 8063

ER  -

TY  - JOUR
AU  - Battegay, M.
TI  - Enhanced establishment of a virus carrier state in adult CD4
+ T-cell-deficient mice.
JA  - J. Virol.
PY  - 1994///
VL  - 68
SP  - 
4700
EP  - 4704
ER  -

TY  - JOUR
AU  - Rosenberg, E. S.
TI  - Vigorous HIV-1-specific CD4+ T cell responses
associated with control of viremia.
JA  - Science
PY  - 1997///
VL  - 278
SP  - 
1447
EP  - 1450
M3  - 10.1126/science.278.5342.1447
N1  - 10.1126/science.278.5342.1447
UR  - http://dx.doi.org/10.1126/science.278.5342.1447
ER  -

TY  - JOUR
AU  - Oxenius, A.
TI  - Early highly active antiretroviral therapy for acute HIV-1
infection preserves immune function of CD8+ and CD4
+ T lymphocytes.
JA  - Proc. Natl Acad. Sci. USA
PY  - 2000///
VL  - 
97
SP  - 3382
EP  - 3387
M3  - 10.1073/pnas.97.7.3382
N1  - 10.1073/pnas.97.7.3382
UR  - http://dx.doi.org/10.1073/pnas.97.7.3382
ER  -

TY  - JOUR
AU  - Malhotra, U.
TI  - Effect of combination antiretroviral therapy on T-cell immunity
in acute human immunodeficiency virus type 1 infection.
JA  - J. Infect.
Dis.
PY  - 2000///
VL  - 181
SP  - 121
EP  - 131
ER  -

TY  - JOUR
AU  - Kalams, S. A.
AU  - 
Walker, B. D.
TI  - The critical need for CD4 help
in maintaining effective cytotoxic T lymphocyte responses.
JA  - J. Exp.
Med.
PY  - 1998///
VL  - 188
SP  - 2199
EP  - 2204
ER  -

TY  - JOUR
AU  - von Herrath, M. G.
AU  - 
Yokoyama, M.
AU  - Dockter, J.

AU  - Oldstone, M. B.
AU  - 
Whitton, J. L.
TI  - CD4-deficient mice have reduced
levels of memory cytotoxic T lymphocytes after immunization and show diminished
resistance to subsequent virus challenge.
JA  - J. Virol.
PY  - 1996///
VL  - 
70
SP  - 1072
EP  - 1079
ER  -

TY  - JOUR
AU  - Zajac, A. J.
TI  - Viral immune evasion due to persistence of activated T cells
without effector function.
JA  - J. Exp. Med.
PY  - 1998///
VL  - 188
SP  - 
2205
EP  - 2213
M3  - 10.1084/JEM.188.12.2205
N1  - 10.1084/JEM.188.12.2205
UR  - http://dx.doi.org/10.1084/JEM.188.12.2205
ER  -

TY  - JOUR
AU  - Kalams, S. A.
TI  - Association between virus-specific cytotoxic T-lymphocyte
and helper responses in human immunodeficiency virus type 1 infection.
JA  - 
J. Virol.
PY  - 1999///
VL  - 73
SP  - 6715
EP  - 6720
ER  -

TY  - JOUR
AU  - Gerlach, J. T.
TI  - Recurrence of hepatitis C virus after loss of virus-specific
CD4(+) T- cell response in acute hepatitis C.
JA  - Gastroenterology

PY  - 1999///
VL  - 117
SP  - 933
EP  - 941
M3  - 10.1016/S0016-5085(99)70353-7
N1  - 10.1016/S0016-5085(99)70353-7
UR  - http://dx.doi.org/10.1016/S0016-5085(99)70353-7
ER  -

TY  - JOUR
AU  - Lechner, F.
TI  - Analysis of successful immune responses in persons infected
with hepatitis C virus.
JA  - J. Exp. Med.
PY  - 2000///
VL  - 191
SP  - 
1499
EP  - 1512
M3  - 10.1084/jem.191.9.1499
N1  - 10.1084/jem.191.9.1499
UR  - http://dx.doi.org/10.1084/jem.191.9.1499
ER  -

TY  - JOUR
AU  - Lisziewicz, J.
TI  - Control of HIV despite the discontinuation of antiretroviral
therapy.
JA  - N. Engl. J. Med.
PY  - 1999///
VL  - 340
SP  - 1683
EP  - 
1684
M3  - 10.1056/NEJM199905273402114
N1  - 10.1056/NEJM199905273402114
UR  - http://dx.doi.org/10.1056/NEJM199905273402114
ER  -

TY  - JOUR
AU  - Ortiz, G. M.
TI  - HIV-1-specific immune responses in subjects who temporarily
contain virus replication after discontinuation of highly active antiretroviral
therapy.
JA  - J. Clin. Invest.
PY  - 1999///
VL  - 104
SP  - R13
EP  - 
R18
ER  -

TY  - JOUR
AU  - Kahn, J. O.
AU  - 
Walker, B. D.
TI  - Acute human immunodeficiency virus
type 1 infection.
JA  - N. Engl. J. Med.
PY  - 1998///
VL  - 339
SP  - 
33
EP  - 39
M3  - 10.1056/NEJM199807023390107
N1  - 10.1056/NEJM199807023390107
UR  - http://dx.doi.org/10.1056/NEJM199807023390107
ER  -

TY  - JOUR
AU  - Lori, F.
TI  - Treatment of human immunodeficiency virus infection with hydroxyurea,
didanosine, and a protease inhibitor before seroconversion is associated with
normalized immune parameters and limited viral reservoir.
JA  - J. Infect.
Dis.
PY  - 1999///
VL  - 180
SP  - 1827
EP  - 1832
ER  -

TY  - JOUR
AU  - Carpenter, C. C.
TI  - Antiretroviral therapy for HIV infection in 1997. Updated
recommendations of the International AIDS Society/USA panel.
JA  - J.
Am. Med. Assoc.
PY  - 1997///
VL  - 277
SP  - 1962
EP  - 1969
ER  -

TY  - JOUR
AU  - Lyles, R. H.
TI  - Natural history of human immunodeficiency virus type 1 viremia
after seroconversion and proximal to AIDS in a large cohort of homosexual
men. Multicenter AIDS Cohort Study.
JA  - J. Infect. Dis.
PY  - 2000///
VL  - 
181
SP  - 872
EP  - 880
M3  - 10.1086/315339
N1  - 10.1086/315339
UR  - http://dx.doi.org/10.1086/315339
ER  -

TY  - JOUR
AU  - Pantaleo, G.
TI  - Major expansion of CD8+ T cells with a predominant
V beta usage during the primary immune response to HIV.
JA  - Nature

PY  - 1994///
VL  - 370
SP  - 463
EP  - 467
M3  - 10.1038/370463a0
N1  - 10.1038/370463a0
UR  - http://dx.doi.org/10.1038/370463a0
ER  -

TY  - JOUR
AU  - Autran, B.
TI  - Positive effects of combined antiretroviral therapy on CD4
+ T cell homeostasis and function in advanced HIV disease.
JA  - 
Science
PY  - 1997///
VL  - 277
SP  - 112
EP  - 116
M3  - 10.1126/science.277.5322.112
N1  - 10.1126/science.277.5322.112
UR  - http://dx.doi.org/10.1126/science.277.5322.112
ER  -

TY  - JOUR
AU  - Evans, D. T.
TI  - Virus-specific cytotoxic T-lymphocyte responses select for
amino-acid variation in simian immunodeficiency virus Env and Nef.
JA  - 
Nature Med.
PY  - 1999///
VL  - 5
SP  - 1270
EP  - 1276
ER  -

TY  - JOUR
AU  - Dhodapkar, M. V.
TI  - Rapid generation of broad T-cell immunity in humans after
a single injection of mature dendritic cells.
JA  - J. Clin. Invest.

PY  - 1999///
VL  - 104
SP  - 173
EP  - 180
ER  -

TY  - JOUR
AU  - Davey, R. T., 
TI  - HIV-1 and T cell dynamics after interruption of highly active
antiretroviral therapy (HAART) in patients with a history of sustained viral
suppression.
JA  - Proc. Natl Acad. Sci. USA
PY  - 1999///
VL  - 96
SP  - 
15109
EP  - 15114
M3  - 10.1073/pnas.96.26.15109
N1  - 10.1073/pnas.96.26.15109
UR  - http://dx.doi.org/10.1073/pnas.96.26.15109
ER  -

TY  - JOUR
AU  - Janssen, R. S.
TI  - New testing strategy to detect early HIV-1 infection for use
in incidence estimates and for clinical and prevention purposes.
JA  - 
J. Am. Med. Assoc.
PY  - 1998///
VL  - 280
SP  - 42
EP  - 48
M3  - 10.1001/jama.280.1.42
N1  - 10.1001/jama.280.1.42
UR  - http://dx.doi.org/10.1001/jama.280.1.42
ER  -

TY  - JOUR
AU  - Little, S. J.
TI  - Reduced antiretroviral drug susceptibility among patients
with primary HIV infection.
JA  - J. Am. Med. Assoc.
PY  - 1999///
VL  - 282
SP  - 
1142
EP  - 1149
M3  - 10.1001/jama.282.12.1142
N1  - 10.1001/jama.282.12.1142
UR  - http://dx.doi.org/10.1001/jama.282.12.1142
ER  -

TY  - GEN
AU  - Brander, C.
AU  - 
Walker, B. D.
TI  - Molecular Immunology Data Base

PY  - 1997///
SP  - IV-50
EP  - IV-60

ER  -

TY  - JOUR
AU  - Goulder, P. J.
TI  - Differential narrow focusing of immunodominant human immunodeficiency
virus gag-specific cytotoxic T-lymphocyte responses in infected African and
caucasoid adults and children.
JA  - J. Virol.
PY  - 2000///
VL  - 74
SP  - 
5679
EP  - 5690
M3  - 10.1128/JVI.74.12.5679-5690.2000
N1  - 10.1128/JVI.74.12.5679-5690.2000
UR  - http://dx.doi.org/10.1128/JVI.74.12.5679-5690.2000
ER  -

TY  - JOUR
AU  - Walker, B. D.
TI  - Long-term culture and fine specificity of human cytotoxic
T-lymphocyte clones reactive with human immunodeficiency virus type 1.
JA  - 
Proc. Natl Acad. Sci. USA
PY  - 1989///
VL  - 86
SP  - 9514
EP  - 
9518
ER  -

TY  - JOUR
AU  - Martinez-Picado, J.
AU  - 
Sutton, L.
AU  - De Pasquale, 
M. P.
AU  - Savara, A. V.
AU  - 
D'Aquila, R. T.
TI  - Human immunodeficiency virus
type 1 cloning vectors for antiretroviral resistance testing.
JA  - 
J. Clin. Microbiol.
PY  - 1999///
VL  - 37
SP  - 2943
EP  - 2951
ER  -

TY  - JOUR
AU  - Kalams, S. A.
TI  - Levels of human immunodeficiency virus type 1-specific cytotoxic
T- lymphocyte effector and memory responses decline after suppression of viremia
with highly active antiretroviral therapy.
JA  - J. Virol.
PY  - 1999///
VL  - 
73
SP  - 6721
EP  - 6728
ER  -
